Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced it has received U.S. Food and Drug ...
Penumbra (NYSE:PEN) announced today that it received FDA clearance for its Thunderbolt thrombectomy platform for stroke.
Analyzing the widening delta between algorithmic polyp tracking and actual reductions in interval colorectal cancer ...
Company outlines long-term strategy surrounding AI-assisted imaging technologies and pre-screening wellness applications ...
The United States Patent and Trademark Office (USPTO) officially issued a new patent to Wayne State University and RediMinds Inc. of Southfield, Michigan. The patent protects a pioneering ...
THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke - enabling faster, more complete clot removal ALAMEDA, Calif., June 11, 2026 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results